Main content

    Autism Clinical Trials

    Sutter Health participates in clinical trials related to Autism throughout their Northern California facilities. See the listing below for an overview of current trials, including contact information. For some trials, more detailed information can be found via the title link to ClinicalTrials.gov.

    Title: A Randomized, Blinded, Placebo-Controlled, Crossover Study to Assess the Efficacy of Stem Cells from Autologous Umbilical Cord Blood to Improve Language and Behavior in Children with Autism (Protocol CB2011Chez).
    Description:  A randomized, blinded, placebo-controlled, crossover study to assess the efficacy of stem cells from autologous umbilical cord blood to improve language and behavior in children with autism.
    Investigator: Michael Chez, MD
    Eligibility: Children.
    Status: Closed to enrollment
    Location: Sutter Medical Center, Sacramento
    Contact: Linh Dang-Chu, CRC,
    (916) 733-4482, Email: DangAL1@sutterhealth.org

    Title: Streptococcal Antibodies in Autism Spectrum Disorders with Catatonia
    Description: Collecting data in patients with neurodevelopmental disorders  presenting with a PANDAS-like syndrome.
    Investigator: Shawn Kile, MD
    Eligibility:
    Status:Active and open to enrollment.Location: Sutter Medical Center, Sacramento
    Contact: Tammy Donnel, CRC 916-453-5994, Email: Donnelt@sutterhealth.org


    > See All Neurology Clinical Trials by Condition